Seer Inc

NASDAQ:SEERUnited States

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

Contact Information

Headquarters

3800 Bridge Parkway, Suite 102REDWOOD CITY, CA, United States 94065

Phone

650-453-0000

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder

Omid Farokhzad

President, Chief Financial Officer, Treasurer

David Horn

Lead Independent Director

Nicolas Roelofs

Director

Robert Langer

Independent Director

Meeta Gulyani